Drawing for SEIKAGAKU

USPTO serial 79070961

SEIKAGAKU

Reviewed by CopyMark Law Group

Reg. 3983398Status 708Registered
Filing date
Status date
Registration date
Jun 28, 2011
Examiner
DELGIZZI, RONALD ERNEST
Law office
—

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with SEIKAGAKU?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mainak H. Mehta

Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP525 B. StreetSuite 2200San Diego, CA 92101

Goods and services

ClassDescriptionStatusFirst use
001(( [ Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, namely, tissue-engineered products, artificial skin products, artificial vitreous body products and anti-adhesive products, and for research purposes in the biomedical field; ] )) Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of (( pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, namely, tissue-engineered products, )) artificial skin products and corneal preservation medium, and for research purposes in the biomedical field; Chemical reagents for scientific, research and quality control purposes, namely, limulus amebocyte lysate reagents for use in analysis of endotoxins (( [ and beta-glucan; Reagents, namely, glycobiological analysis reagents for clinical and medical laboratory use, and diagnostic preparations and reagents for clinical and medical laboratory use ] ))ACTIVE—
005(( Joint function improving agents, namely, pharmaceutical preparations for treating arthrosis and other joint diseases; [ Ophthalmic surgical aid, namely, sodium hyaluronate solution used for surgery in and around the eyes; Pharmaceutical preparations for the treatment of disc hernia; ] Syringes sold filled with pharmaceuticals, namely, crosslinked or non-crosslinked hyaluronic acid based gel for the treatment of arthrosis and osteoarthritis; Syringes sold filled with pharmaceuticals, namely, sodium hyaluronate solutions for the treatment of arthrosis and osteoarthritis )) [ ; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposes, namely, diagnostic reagents for in-vitro clinical diagnostic purposes ]ACTIVE—
010[ Injection syringes ; Injection needles ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 24, 2022INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Sep 26, 2022INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 26, 2022INPCINVALIDATION PROCESSED—
Aug 22, 2022INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 22, 2021NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Dec 22, 2021C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Dec 8, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 16, 2021ES75TEAS SECTION 71 & 15 RECEIVED—
Jun 28, 2020REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Mar 28, 2019RNWLINTERNATIONAL REGISTRATION RENEWED—
Apr 13, 2018INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Mar 8, 2018INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 8, 2018INPCINVALIDATION PROCESSED—
Feb 26, 2018INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 26, 2017NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jun 26, 2017NA15SEC. 15 ACKNOWLEDGEMENT - E-MAILED—
Jun 26, 201771AGREGISTERED-SEC.71 ACCEPTED—
Jun 26, 201715AKREGISTERED - SEC. 15 ACKNOWLEDGED—
Jun 26, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 23, 201771AFREGISTERED-SEC.71 FILED—
May 23, 201715AFREGISTERED - SEC. 15 AFFIDAVIT FILED—
May 23, 2017ES71TEAS SECTION 71 RECEIVED—
May 23, 2017E15RTEAS SECTION 15 RECEIVED—
Aug 15, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 3, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 2, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 1, 2011FIMPFINAL DISPOSITION PROCESSED—
Sep 28, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 28, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 16, 2011OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 12, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 12, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 24, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 24, 2011OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 5, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 5, 2011ALIEASSIGNED TO LIE—
Feb 8, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 8, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Feb 8, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 8, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 8, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 28, 2011OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 13, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 13, 2011OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 8, 2010GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 8, 2010GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 8, 2010CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 28, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 27, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 27, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 3, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 1, 2010ALIEASSIGNED TO LIE—
Feb 27, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 17, 2010ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 17, 2010REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 29, 2009RFNTREFUSAL PROCESSED BY IB—
Aug 27, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 27, 2009RFRRREFUSAL PROCESSED BY MPU—
Aug 25, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 24, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 14, 2009DOCKASSIGNED TO EXAMINER—
Aug 14, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 13, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance